6-K
Fresenius Medical Care AG (FMS)
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER
Pursuant to Rule 13a-16 or 15d-16 of the
Securities Exchange Act of 1934
For the month of December 2024
Commission file number: 001-32749
FRESENIUS MEDICAL CARE AG
(Translation of registrant's name into English)
Else-Kröner Strasse 1
61346 Bad Homburg
Germany
(Address of principal executive offices)
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.
Form 20-F x Form 40-F ¨
EXHIBITS
The following exhibits are being furnishedwith this Report:
| Exhibit 99.1 | Convenience translation of the announcement pursuant to section 248a sentence 1 of the German Stock Corporation Act. |
|---|
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
DATE: December 12, 2024
| Fresenius Medical Care AG | |
|---|---|
| By: | /s/ Helen Giza |
| Name: | Helen Giza |
| Title: | Chief Executive Officer and Chair of the Management Board |
| By: | /s/ Martin Fischer |
| Name: | Martin Fischer |
| Title: | Chief Financial Officer and member of the Management Board |
Exhibit 99.1
Convenience translation
Fresenius Medical Care AG
Hof
ISIN: DE0005785802 // WKN: 578580
ISIN: US3580291066 // CUSIP: 358029106
Announcement pursuant to section 248a sentence 1 of the German Stock Corporation Act (Aktiengesetz – AktG)
In accordance with section 248a sentence 1 AktG, we hereby announce the following: The action for defective resolution (Beschlussmängelklageverfahren) brought before the Regional Court of Nuremberg-Fürth (Landgericht Nürnberg-Fürth) (file number: 1 HK O 4610/23), in which individual shareholders of the Company had objected to the resolution passed at the Extraordinary General Meeting of the Company on July 14, 2023 regarding the change of the Company's legal form to that of a stock corporation, has been terminated. This proceeding had been combined as the leading proceeding with the action for defective resolution initially initiated at the Regional Court of Frankfurt a.M. (Landgericht Frankfurt a.M.) under the then file number 3-05 O 539/23, after the proceedings initiated at the Regional Court of Frankfurt a.M. had been referred to the Regional Court of Nuremberg-Fürth.
The termination of the related proceeding before the District Court of Nuremberg-Fürth is based on the fact that all shareholders who had filed actions for rescission or nullity against the resolution in question have withdrawn their actions. No agreements were concluded between the Company and the plaintiffs.
Hof, this December 2024
Fresenius Medical Care AG
The Management Board